Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Albert David's Pre-Tax Income for the
three
months ended in Mar. 2026 was ₹-252 Mil. Albert David's Revenue for the
three
months ended in Mar. 2026 was ₹859 Mil. Therefore, Albert David's pretax margin for the quarter that ended in Mar. 2026 was -29.39%.
The historical rank and industry rank for Albert David's Pretax Margin % or its related term are showing as below:
NSE:ALBERTDAVD'
s Pretax Margin % Range Over the Past 10 Years
Min: 0.16 Med: 9.24 Max: 27
Current: 0.16
NSE:ALBERTDAVD's Pretax Margin % is ranked worse than 66.95% of 956
companies
in the Drug Manufacturers industry
Industry Median: 7.285
vs NSE:ALBERTDAVD: 0.16
Albert David (NSE:ALBERTDAVD) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Albert David Pretax Margin % Related Terms
Albert David Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Albert David's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ALBERTDAVD vs ZTS, UTHR: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Albert David's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Albert David Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Albert David's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Albert David's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Albert David (NSE:ALBERTDAVD) has a Pretax Margin % of -29.39% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Albert David and its competitors. Over the past decade, Albert David's Pretax Margin % has ranged from 0.16 to 27.00. According to the industry distribution chart, Albert David ranks #640 out of 956 companies in the Drug Manufacturers industry, placing it in the top 66.9%.
Is Albert David's Pretax Margin % too high?
Albert David's current Pretax Margin % is -29.39%. Over the past 10 years, this metric has ranged from a low of 0.16 to a high of 27.00. Based on the distribution chart, Albert David ranks #640 out of 956 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Albert David has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Albert David's Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Albert David ranks #640 out of 956 companies for Pretax Margin %. This places Albert David in the lower half of its industry. The industry median Pretax Margin % is 7.29. Historically, Albert David's own Pretax Margin % has ranged from 0.16 to 27.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.29, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Albert David and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Albert David's current Pretax Margin % is -29.39%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Albert David stock overvalued right now?
Based on GuruFocus' analysis, Albert David (NSE:ALBERTDAVD) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹830.07, compared to a current price of ₹701.00 — trading 15.5% below its estimated fair value. The current Pretax Margin % is -29.39%. Albert David's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Albert David (NSE:ALBERTDAVD), the current Pretax Margin % is -29.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Albert David (NSE:ALBERTDAVD) Overvalued in 2026?
Based on GuruFocus' analysis, Albert David stock appears to be undervalued.
The current stock price of ₹701.00 is trading 15.5% below its estimated GF Value™ of ₹830.07.
GuruFocus considers Albert David to be Modestly Undervalued.
Key valuation signals for NSE:ALBERTDAVD:
Pretax Margin %: -29.39%
GF Value™: ₹830.07 vs. price of ₹701.00 (15.5% below fair value)
No single metric tells the full story. See the NSE:ALBERTDAVD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Albert David Ltd is engaged in the manufacturing and trading of pharmaceutical products. The company offers products such as pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs. Its formulation product covers parenteral, oral, enteral, topical agents, and vision care solutions. The company exports its product to regions like Latin America, Southeast Asia, and a few African countries. The Company is only engaged in the manufacturing of pharmaceutical products, ipso facto, one reportable segment.
75GF Score
Get the complete analysis for NSE:ALBERTDAVD
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ALBERTDAVD has been successfully added to your 
